Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
217.00    -2.00 (-0.91%)
Bid:
217.00
Ask:
217.50
Spread: 0.50 (0.23%)
Market Cap: £599.82m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

AGM Trading Update

7 May 2026 07:00

RNS Number : 2808D
Morgan Advanced Materials PLC
07 May 2026
 

Press Release

Morgan Advanced Materials plc

7 May 2026

 

AGM Trading Update

Trading in-line; full-year guidance maintained

 

Morgan Advanced Materials plc, the global leader in advanced ceramics and carbon systems for technologically demanding applications, announces a trading update in advance of its 2026 Annual General Meeting being held later today.

Current Trading

During the first quarter, we continued to see broad based order intake stability across the Group's divisions and end-markets. Noting the weak prior year comparator, and as expected, the Group delivered organic constant currency revenue1 growth of 6.2%.

2026 Outlook

Q1 trading was in line with expectations and our full year outlook for 2026 remains unchanged. 

We have not observed any material direct or indirect trading impact from the conflict in the Middle East in Q1, and are responding through pricing to offset inflationary impacts. We will continue to monitor this evolving situation including any further impact from the situation becoming prolonged.

Damien Caby, Chief Executive Officer, commented:

"Our Q1 trading was in line with our expectations and today we reconfirm our full year guidance for 2026. We are making good progress against our strategic priorities, including the strategic review of Thermal Products, and continue to focus on executing at pace against the strategy set out at our December 2025 Capital Markets Day."

 

For further information, please contact:

Richard Armitage, CFO

Morgan Advanced Materials

01753 837 000

Nicholas Frost, Investor Relations

 

 

 

Media enquiries:

Nina Coad

Brunswick

0207 404 5959

 

1'Organic constant currency revenue': Group revenue excluding acquisition, disposal and business exit impacts with the current and prior year results translated at current year average exchange rates

Important notice

This announcement contains forward-looking statements. These statements have been made in good faith based on the information available up to the time of the approval of this announcement. No assurance can be given that these expectations will prove to have been correct. By their nature, forward-looking statements involve risks, uncertainties or assumptions that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. As such, undue reliance should not be placed on forward-looking statements.

The Directors undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEADSKEEFKEFA
Date   Source Headline
30th Nov 20113:26 pmRNSScrip Dividend Price
30th Nov 20111:16 pmRNSHolding(s) in Company
29th Nov 20114:06 pmRNSHolding(s) in Company
25th Nov 20119:41 amRNSDirector/PDMR Shareholding
14th Nov 20117:00 amRNSInterim Management Statement
18th Oct 20119:29 amRNSHolding(s) in Company
5th Oct 20115:50 pmRNSHolding(s) in Company
4th Oct 20119:57 amRNSDirector/PDMR Shareholding
12th Sep 201112:16 pmRNSDirector/PDMR Shareholding
31st Aug 20114:08 pmRNSHolding(s) in Company
24th Aug 201112:33 pmRNSDirector/PDMR Shareholding
11th Aug 20119:45 amRNSHalf Yearly Report
1st Aug 20119:35 amRNSTotal Voting Rights
20th Jul 20113:10 pmRNSDirector/PDMR Shareholding
13th Jul 20117:00 amRNSTrading Statement
8th Jul 20115:40 pmRNSDirector/PDMR Shareholding
8th Jul 20115:27 pmRNSTotal Voting Rights
1st Jul 201111:06 amRNSIssue of Equity
15th Jun 201112:03 pmRNSBlocklisting Interim Review
25th May 20119:57 amRNSScrip Dividend Price
11th May 20113:32 pmRNSResult of AGM
10th May 20117:00 amRNSInterim Management Statement
18th Apr 20112:59 pmRNSAnnual Information Update
8th Apr 20113:30 pmRNSDirector/PDMR Shareholding
8th Apr 201112:23 pmRNSHolding(s) in Company
8th Apr 201112:21 pmRNSDirector/PDMR Shareholding
6th Apr 20115:00 pmRNSDirector/PDMR Shareholding
31st Mar 20117:00 amRNSAnnual Financial Report
31st Mar 20117:00 amRNSCapital Markets Presentation
25th Mar 20114:01 pmRNSHolding(s) in Company
25th Mar 20113:57 pmRNSDirector/PDMR Shareholding
24th Mar 20115:10 pmRNSDirector/PDMR Shareholding
24th Mar 20113:03 pmRNSDirector/PDMR Shareholding
15th Mar 20116:00 pmRNSHolding(s) in Company
15th Mar 20115:58 pmRNSHolding(s) in Company
4th Mar 20115:09 pmRNSDirector/PDMR Shareholding
28th Feb 20115:27 pmRNSTotal Voting Rights
16th Feb 20117:00 amRNSFull Year Results
31st Jan 201110:26 amRNSTotal Voting Rights
28th Jan 20111:33 pmRNSAppointment as a Non-Executive Director
17th Jan 20113:20 pmRNSHolding(s) in Company
17th Jan 20113:20 pmRNSDirector/PDMR Shareholding
14th Jan 20117:00 amRNSAcquisition
13th Jan 201110:15 amRNSAppointment of Tim Stevenson to Johnson Matthey
12th Jan 20111:21 pmRNSHolding(s) in Company
12th Jan 20119:34 amRNSDirector/PDMR Shareholding
12th Jan 20119:30 amRNSTotal Voting Rights
5th Jan 201110:40 amRNSIssue of Shares under Scrip Dividend Scheme
15th Dec 20104:04 pmRNSBlocklisting Interim Review
8th Dec 20104:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.